Insider Stock Trading History of Barth Jay


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Barth Jay since year 2005. The trader's CIK number is 1601896. At the time of this reporting, Barth Jay is the Chief Medical Officer of Amicus Therapeutics Inc . (stock ticker symbol FOLD). See this page for all insider trading activities at Amicus Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Barth Jay since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-04-12 FOLD Amicus Therapeutics Inc Option Ex 5,000 2.29 11,450
2018-04-12 FOLD Amicus Therapeutics Inc Sale 5,000 14.72 73,600
2018-03-12 FOLD Amicus Therapeutics Inc Option Ex 5,000 2.29 11,450
2018-03-12 FOLD Amicus Therapeutics Inc Sale 5,000 15.05 75,255
2018-01-23 FOLD Amicus Therapeutics Inc Option Ex 20,000 2.29 45,800
2018-01-23 FOLD Amicus Therapeutics Inc Sale 20,000 16.80 336,000
2018-01-02 FOLD Amicus Therapeutics Inc Option Ex 5,000 14.71 73,560
2018-01-02 FOLD Amicus Therapeutics Inc Sale 5,000 14.71 73,560
2017-12-01 FOLD Amicus Therapeutics Inc Option Ex 5,000 13.59 67,935
2017-12-01 FOLD Amicus Therapeutics Inc Sale 5,000 13.59 67,935
2017-10-12 FOLD Amicus Therapeutics Inc Option Ex 5,000 14.25 71,270
2017-10-12 FOLD Amicus Therapeutics Inc Sale 5,000 14.25 71,270
2017-06-19 FOLD Amicus Therapeutics Inc Sale 30,000 10.00 300,000
2017-06-15 FOLD Amicus Therapeutics Inc Option Ex 1,629 8.79 14,318
2017-06-19 FOLD Amicus Therapeutics Inc Option Ex 30,000 10.00 300,000
2016-08-04 FOLD Amicus Therapeutics Inc Sale 10,458 7.00 73,206
2016-07-27 FOLD Amicus Therapeutics Inc Sale 20,916 7.00 146,412
2015-12-03 FOLD Amicus Therapeutics Inc Option Ex 25,000 .00 0
2015-05-08 FOLD Amicus Therapeutics Inc Option Ex 25,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Barth Jay (Chief Medical Officer of Amicus Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.